OneMedNet inks deal with top medical device leader for real-world data services.
PorAinvest
lunes, 25 de agosto de 2025, 7:58 am ET1 min de lectura
ONMD--
The collaboration leverages OneMedNet's extensive iRWD™ network, which spans over 1,750 provider sites. The company has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement [1].
OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability [1].
The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition [1].
What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development—the need for diverse, interconnected data types that reflect real-world clinical scenarios [1].
The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals [1].
The partnership underscores OneMedNet's ability to deliver high-quality, diverse data sets that meet the rigorous standards demanded by leading healthcare brands. This collaboration is expected to drive further innovation in medical imaging AI and contribute to improved patient outcomes [1].
References:
[1] https://www.stocktitan.net/news/ONMD/one-med-net-expands-multiple-revenue-delivering-projects-under-4mphg3ibu805.html
OneMedNet Corporation, a leader in AI-powered Real-World Data, has announced significant adoption by one of the world's top five medical device leaders. The company has entered into a master services agreement with a renowned medical device innovator, providing for an evergreen engagement with no fixed term. The agreement includes four distinct purchase orders for OneMedNet's Real-World Data, focused on delivering diverse, regulatory-grade multi-modal data to accelerate innovation in medical imaging AI model development.
OneMedNet Corporation (Nasdaq:ONMD), a leading provider of AI-powered Real-World Data (RWD), has announced a significant expansion in its partnership with one of the world's top five medical device companies. The company has entered into a master services agreement with the renowned innovator, providing for an evergreen engagement with no fixed term. This agreement includes four distinct purchase orders for OneMedNet's RWD, focused on delivering diverse, regulatory-grade multi-modal data to accelerate innovation in medical imaging AI model development [1].The collaboration leverages OneMedNet's extensive iRWD™ network, which spans over 1,750 provider sites. The company has already begun fulfilling these recent orders, demonstrating its efficient execution capabilities in providing curated, de-identified, and fit-for-purpose datasets for AI development, clinical trial enhancement, and healthcare outcome improvement [1].
OneMedNet's announcement represents a significant commercial expansion with one of healthcare's most influential players. The evergreen master services agreement is particularly valuable as it establishes an ongoing revenue relationship without a fixed termination date, reducing customer acquisition costs and providing greater revenue predictability [1].
The four separate purchase orders indicate diverse use cases for OneMedNet's real-world data, suggesting their platform has multiple applications within a single organization. This demonstrates product versatility and increases potential wallet share from each customer. The immediate commencement of delivery on these orders confirms operational readiness and suggests near-term revenue recognition [1].
What truly differentiates OneMedNet in the competitive healthcare data landscape is their multimodal data offering. By combining advanced medical imaging with comprehensive patient histories and clinical notes, they're delivering the contextual richness necessary for developing sophisticated AI models. This comprehensive approach addresses a critical challenge in healthcare AI development—the need for diverse, interconnected data types that reflect real-world clinical scenarios [1].
The company's network spanning 1,750+ provider sites represents a substantial competitive moat. Building such extensive provider relationships requires significant time investment and regulatory navigation, creating barriers to entry for competitors. The emphasis on regulatory-grade data quality further strengthens their market position, particularly for customers developing products requiring FDA or other regulatory approvals [1].
The partnership underscores OneMedNet's ability to deliver high-quality, diverse data sets that meet the rigorous standards demanded by leading healthcare brands. This collaboration is expected to drive further innovation in medical imaging AI and contribute to improved patient outcomes [1].
References:
[1] https://www.stocktitan.net/news/ONMD/one-med-net-expands-multiple-revenue-delivering-projects-under-4mphg3ibu805.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios